Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biosense Webster
MedTech
FDA approves J&J’s Varipulse pulsed field ablation system
J&J joins Medtronic and Boston Scientific in the rapidly growing sector for treating atrial fibrillation.
Conor Hale
Nov 7, 2024 3:00pm
J&J consolidates medtech brands under single banner
Sep 10, 2024 10:30am
J&J pulsed field ablation study shows 25% done with zero X-rays
May 21, 2024 11:30am
J&J brings AI update to its heart-mapping Carto 3 system
May 8, 2024 10:15am
J&J nets CE mark for Varipulse pulsed field ablation system
Feb 29, 2024 10:33am
J&J's Biosense Webster puts forward pulsed field ablation data
Feb 5, 2024 10:40am
